Executive Insights for Life Sciences Innovators

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Ryan Beal, M.D., Founder and CEO of Dyve Biosciences. Ryan discusses how Dyve is working to translate decades of research on tumor acidity into new therapeutic approaches for cancer. The conversation explores how an acidic tumor microenvironment can suppress immune function and limit treatment effectivene...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Mark Rutledge, President and CEO of World Precision Instruments. Mark discusses how evolving research needs are reshaping the tools and technologies used in preclinical science. The conversation explores the growing importance of more standardized and physiologically relevant in vitro models, including or...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Justin Byers, Founder and CEO of Axio BioPharma. Justin discusses why the next generation of AI-enabled biomanufacturing depends on something more fundamental than better algorithms: better access to structured, contextualized process data. The conversation explores how fragmented information across labs,...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dhruv Patwardhan, Founder of LuminOne. Dhruv discusses how AI can improve commercial decision-making in life sciences by helping teams make better use of fragmented market, account, and customer signals. The conversation explores where AI is genuinely useful today, why many implementations stall after the...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Pawel Krysiak, President & CEO of Jaya Biosciences. Pawel discusses JayaBio’s work to develop CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia. The conversation explores JayaBio’s focus on lysosomal enzyme g...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with David Pass, CEO and President of AltrixBio. David discusses AltrixBio’s work to advance AJN003, a once-daily, oral, gut-targeted therapeutic candidate being developed for type 2 diabetes, obesity, and related cardiometabolic conditions. The conversation explores how AltrixBio’s approach is inspired by the...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dave Gallup, Co-Founder and CEO of EMPIRI, an oncology platform company advancing functional precision oncology through its E-slice platform. Dave discusses how EMPIRI is using live human tumor tissue to measure drug response while preserving native tumor architecture and the tumor microenvironment. The c...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dr. Anil Goyal, Co-Founder and CEO of IMMvention Therapeutix, a VC-backed biotechnology company developing globally accessible therapies for rare and chronic diseases, including sickle cell disease and Friedreich’s ataxia. Anil shares insights from nearly 30 years in biotechnology leadership spanning comp...

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Stan Watowich, Founder and CEO of Ridgeline Therapeutics and Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch. Stan shares his journey from academic science to biotech company building, and how Ridgeline is developing small molecule therapies aimed at improving how...

In this episode of Executive Insights for Life Sciences Innovators, we speak with Michael Heltzen, CEO of eXoZymes, a publicly traded biotechnology company developing AI-enabled, cell-free biomanufacturing platforms designed to expand what is possible with enzyme engineering. Michael discusses the company’s thesis that producing complex molecules outside living cells may allow greater control, sca...

In this episode of Executive Insights for Life Sciences Innovators, we speak with Charles Legg of CureLab Oncology, a biotechnology company developing novel immuno-oncology therapies designed to more precisely modulate immune pathways within the tumor microenvironment. Charles shares his perspective on how immunotherapy continues to evolve beyond first-generation checkpoint inhibitors and why a de...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Christopher Gropp, Founder and CEO of Trialogics , a clinical trial technology company developing integrated platforms designed to improve how clinical research data is captured, managed, and utilized across global studies. Chris shares his journey building technology solutions for clinical research and explains why...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Chris Hoyt, CEO of KeifeRx , a pre-clinical stage biotechnology company developing small molecule therapies for neurodegenerative diseases based on technology licensed from Georgetown University. Chris shares his journey as an entrepreneurial executive who has launched, funded, and scaled venture-backed companies ac...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Ben Scruggs, the CEO of Altis Biosciences , a biotechnology company developing advanced human intestinal tissue platforms designed to improve the predictability of drug development. Ben explains how Altis’ RepliGut® platform addresses long-standing limitations in traditional preclinical gut models, which often fail...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Murat Croci , Co-CEO of Ibex Biosciences , a biotechnology company developing novel therapies to address major unmet medical needs in oncology and infectious disease. Murat discusses how Ibex is advancing high-conviction therapeutic programs from preclinical success toward the clinic, and the discipline required to...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Gitte Pedersen , founder and CEO of Genomic Expression , a life sciences company focused on advancing RNA-based diagnostics to improve cancer care. Gitte discusses how Genomic Expression is applying RNA sequencing and data-driven diagnostics to help clinicians identify the most effective treatment options for indivi...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Jason Kralic , CEO and co-founder of Tellus Therapeutics , a biotechnology company focused on developing novel therapies for neonatal brain injury. Jason discusses how Tellus is building a translational biotech platform grounded in strong biological insight and disciplined execution, with a clear focus on addressing...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Karthik Sriram , Vice President of Financial Planning & Analysis at Parabilis Medicines , a biopharmaceutical company developing next-generation peptide therapeutics through its innovative Helicon™ platform. Karthik discusses how Parabilis is applying platform science and strategic financial planning to advance...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Jim Buck, President & CEO of Medcura , a medical device company advancing surgical safety through innovative hemostatic and wound treatment solutions. Jim discusses how Medcura is addressing one of healthcare’s most persistent challenges, rapid and reliable bleeding control, through a platform built on biocompat...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Mike Stocum of Bantam Pharmaceutical , a biotech developing therapies that target cancer cells through their mitochondria. Mike shares how Bantam is advancing its lead programs and building a strategy to translate cutting-edge science into new treatment options for patients. Learn more at ⁠ genecoda.com ⁠. Originall...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Mark Stead of Atomic AI , a biotech harnessing artificial intelligence and structural biology to unlock RNA’s therapeutic potential. Mark shares how Atomic AI is building a discovery platform to model RNA structures with unprecedented accuracy, opening the door to new classes of medicines for oncology, rare diseases...

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Larry Tiffany, CEO of GenrAb , to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the chall...

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences , a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision med...

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Darren Dasburg, CEO of Clarus Biologics , a company advancing vaccine and immunology innovation through a novel adjuvant platform designed to improve immune responses, particularly in vulnerable populations. Darren shares insights on Clarus Biologics’ technology, its potential applications in global health, and t...

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Ayla Annac, CEO and Co-Founder of InvivoSciences , a precision medicine company transforming the way therapies are discovered and developed for heart failure and cardiometabolic diseases. Ayla shares insights into InvivoSciences’ innovative platform, the promise of patient-specific models in drug discovery, and t...